Clinical Trials Browser

Terminated × Neoplasms, Plasma Cell × Vorinostat × Clear all

NCT00744354 2018-01-18

Vorinostat, Bortezomib, and Doxorubicin Hydrochloride Liposome in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase 1 Terminated

Multiple Myeloma, Neoplasms, Plasma Cell